YHR2603: Clinical Trials

1 trial of YHR2603, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow YHR2603: new trials by email Literature Review of YHR2603 trials Research Report on YHR2603

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects
YHP2508C, YHR2603 - Healthy Subjects
Phase 1CompletedYuhan Corporation462026-07-102026-10-01

Sponsors

Yuhan Corporation (1)

Countries

South Korea (1)